PVLA · Stock research · Public disclosure research
Palvella Therapeutics, Inc.
Data as of Oct 14, 2026. Collected disclosures, not exhaustive history.
30-day and 12-month windows end Oct 15, 2026 and use transaction dates, not disclosure dates. The data-as-of date above reflects the latest collected disclosure and may be older than the window end.
For transactions dated in the 30-day window ending Oct 15, 2026, collected disclosures for Palvella Therapeutics, Inc. (PVLA) show 17 sales by insiders. Net reported purchase less sale value is -$3,579,474.00.
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 2,072 | $122.62 | $254,058.00 | 137,242 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 2,604 | $123.29 | $321,046.00 | 134,638 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 476 | $121.14 | $57,663.00 | 139,314 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 505 | $126.55 | $63,910.00 | 132,616 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 597 | $125.33 | $74,820.00 | 133,121 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 920 | $124.37 | $114,416.00 | 133,718 | Oct 14, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 1,035 | $131.49 | $136,092.00 | 141,291 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 1,644 | $129.23 | $212,455.00 | 143,316 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 2,004 | $128.52 | $257,555.00 | 144,960 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 579 | $132.40 | $76,662.00 | 140,712 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 922 | $133.72 | $123,292.00 | 139,790 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 990 | $130.48 | $129,175.00 | 142,326 | Oct 13, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 1,447 | $135.50 | $196,064.00 | 147,781 | Oct 12, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 2,458 | $133.25 | $327,524.00 | 152,563 | Oct 12, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 3,335 | $134.21 | $447,586.00 | 149,228 | Oct 12, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 5,095 | $132.62 | $675,681.00 | 155,021 | Oct 12, 2026 | Oct 14, 2026Source record |
| JENKINS GEORGE MDirector | Open-market saleNon-derivative security10b5-1: — | 817 | $136.44 | $111,475.00 | 146,964 | Oct 12, 2026 | Oct 14, 2026Source record |
Review the entire collected insider disclosure history with a free account.
Full collected history is available here after sign-in, separate from the public 12-month window. It is not an exhaustive trading history.
The largest open-market transaction by reported value in the public window was an open-market sale by JENKINS GEORGE M on Oct 12, 2026: $675,681.00, involving 5,095 shares. Reported price: $132.62.
0 public-window transactions explicitly indicate a 10b5-1 plan. A missing indication is not proof that a transaction was discretionary. Prices and values are shown only when reported; unavailable fields are not filled with zero.
Collected disclosures show 0 open-market purchases and 17 sales with transaction dates in the trailing 30 days ending Oct 15, 2026. Net reported purchase less sale value is -$3,579,474.00. The latest collected disclosure data is as of Oct 14, 2026. These counts do not represent every insider action.
1 distinct insiders appear in collected disclosures for transaction dates in the trailing 30 days ending Oct 15, 2026. The latest collected Form 4 was filed on Oct 14, 2026. A filing date is not the transaction date.
This page shows 17 collected transactions dated in the trailing 12 months ending Oct 15, 2026. 0 older collected transactions are summarized outside this window and can be viewed here after sign-in. This is collected disclosure coverage, not exhaustive history; 10b5-1 plan status and derivative securities are labeled per record.
Insider data covers the trailing 12 months on public tables. Congressional tables cover all saved disclosures. Neither is an exhaustive history. Form 4 filing dates and congressional disclosure dates may differ from trade dates. Congressional amounts are ranges, not estimated dollar totals. Disclosure activity alone does not establish intent or predict returns.
From disclosure to research
Create a workspace for filing analysis and research notes. Filing-alert availability depends on your plan. Review the plan features separately; opening the plans page does not create an alert.